Ratnakar Securities Pvt. Ltd.

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis

BSE1651.35-27.75 (-1.65 %)

PREV CLOSE ( ) 1679.10

OPEN PRICE ( ) 1679.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 845

TODAY'S LOW / HIGH ( )1644.20 1679.65

52 WK LOW / HIGH ( )1383.7 2306.85

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-11 2000

Management Info

Sushil Shah - Chairman Ameera Shah - Managing Director

Registered Office

Address 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022 6258 2810 / 8422 801 801

Email support@metropolisindia.com / secretarial@metropolisindia.com

Website www.metropolisindia.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

31May Metropolis Healthcare submits analyst
Pursuant to Regulation 30(6) of the Listing Regulations, Metropolis Heal..

24May Metropolis Healthcare informs about di
Metropolis Healthcare has informed that Dapic Metropolis Healthcare (for..

07Apr Metropolis Healthcareâ€™s arm to acqui
Metropolis Healthcareâ€™s wholly owned subsidiary -- Metropolis Histoxpe..

07Apr Metropolis Healthcare informs about di
Pursuant to Regulation 30 of the Listing Regulations, Metropolis Healthc..

28Mar Metropolis Healthcare informs about di
Metropolis Healthcare has informed that the exchange has received the di..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	238.5	1247.97
Gross Profit	286.34	1620.24
Operating Profit	603.36	2851.73
Net Sales	3119.53	12165.43

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE) 6941.70 (0.98%)	M.Cap ( in Cr)99811.00
Dr Agarwals Eye Hsp (BSE) 4398.25 (1.06%)	M.Cap ( in Cr)2067.18
Max Healthcare Inst (BSE) 1168.45 (2.73%)	M.Cap ( in Cr)113590.50
Yatharth Hospital (BSE) 540.55 (5.97%)	M.Cap ( in Cr)5208.43
Krsnaa Diagnostics (BSE) 675.35 (3.75%)	M.Cap ( in Cr)2180.69

Shareholding Pattern

	NON-INSTITUTION	5.52%
	PROMOTERS	48.9%
	FI/BANKS/INSURANCE	3.75%
	MUTUAL FUNDS/UTI	26.42%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
NJ ELSS Tax Saver S...	3.25
HDFC Pharma and Hea...	2.26
LIC MF Healthcare F...	2.23
Tata India Pharma &...	1.80
HDFC Focused 30 Fund(G)	1.54
UTI Healthcare Fund...	1.50

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

METROPOLIS HEALTHCARE LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES